MENU
SION
AS OF
Feb 4, 01:30 PM (EDT)
Price
$43.80
Change
-$0.68 (-1.53%)
Capitalization
1.98B
43 days until earnings call
Intraday BUY SELL Signals
+Compare
SION
Stock ticker: NASDAQ
AS OF
Feb 4, 01:30 PM (EDT)
Price
$43.80
Change
-$0.68 (-1.53%)
Capitalization
1.98B

SION Sionna Therapeutics Inc Forecast, Technical & Fundamental Analysis

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients... Show more

SION
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SION with price predictions
Feb 03, 2026

SION's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SION turned positive on January 22, 2026. Looking at past instances where SION's MACD turned positive, the stock continued to rise in of 9 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 23, 2026. You may want to consider a long position or call options on SION as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

SION moved above its 50-day moving average on January 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SION crossed bullishly above the 50-day moving average on January 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SION advanced for three days, in of 51 cases, the price rose further within the following month. The odds of a continued upward trend are .

SION may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 44 cases where SION Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SION’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.158) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SION’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SION
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SION is expected to report earnings to rise 54.35% to -70 cents per share on March 19

Sionna Therapeutics Inc SION Stock Earnings Reports
Q4'25
Est.
$-0.71
Q3'25
Beat
by $0.14
Q2'25
Beat
by $0.11
The last earnings report on November 05 showed earnings per share of -46 cents, beating the estimate of -60 cents. With 15.06K shares outstanding, the current market capitalization sits at 1.98B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALPCX10.960.07
+0.64%
American Century Focused Lg Cap Val C
STRAX39.070.19
+0.49%
Sterling Capital Behav Lg Cp Val Eq R6
RRRCX21.760.08
+0.37%
DWS RREEF Real Estate Securities C
TRZIX18.420.06
+0.33%
T. Rowe Price Small-Cap Index Z
TWRCX42.62-0.90
-2.07%
American Century Growth C